EurekAlert!1mon
Liver function discovery could lead to better cardiovascular disease treatments
is affected by the rate blood flows into the liver via the ‘portal’ vein from the intestine. Previous research has shown that blood flow in the portal vein increases and decreases throughout ...
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024
Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...
EurekAlert!17d
The imbalance of homeostasis in neutrophil extracellular traps is associated with portal vein thrombosis in patients with decompensated cirrhosis
Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive ...
News Medical1mon
Liver function discovery could revolutionize treatments for cardiovascular disease
is affected by the rate blood flows into the liver via the 'portal' vein from the intestine. Previous research has shown that blood flow in the portal vein increases and decreases throughout the ...